Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting

Despite relevant medical advancements, metastatic breast cancer remains an uncurable disease. HER2 signaling conditions tumor behavior and treatment strategies of HER2 expressing breast cancer. Cancer treatment guidelines uniformly identify dual blockade with pertuzumab and trastuzumab plus a taxane...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Prete, Salvatore Del, Montella, Liliana, Arpino, Grazia, Buono, Giuseppe, Buonerba, Carlo, Dolce, Pasquale, Fiorentino, Olga, Aliberti, Maria, Febbraro, Antonio, Savastano, Clementina, Colantuoni, Giuseppe, Riccardi, Ferdinando, Ruggiero, Angela, Placido, Sabino De, Orditura, Michele
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2020
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7275781/
https://ncbi.nlm.nih.gov/pubmed/32547706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27603
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料